The medical field is seeing a major shift in glucose treatment with the introduction of GLP-1 transdermal devices. These groundbreaking vehicles offer a likely simple option to injections for individuals managing type 2 diabetes. By circumventing the requirement for frequent needles, GLP-1 adhesives promise to enhance patient compliance and general